NYSE - Delayed Quote USD

Charles River Laboratories International, Inc. (CRL)

Time to buy CRL?

138.79

-2.57

(-1.82%)

At close: May 9 at 4:00:02 PM EDT

138.79

0.00

(0.00%)

After hours: May 9 at 6:22:52 PM EDT

Time to buy CRL?

Eli Lilly extends Purdue alliance; EMA investigates Valneva shot

The big pharma will spend up to $250 million over the next eight years of the collaboration. Elsewhere, CRISPR Therapeutics unveiled new data and Vivo Capital raised funds.

BioPharma Dive 2 days ago

LLY

CRL
-1.82%

VLA.PA
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

Charles River Laboratories International, Inc. ( NYSE:CRL ), is not the largest company out there, but it received a...

Simply Wall St. 3 days ago

CRL
-1.82%
Charles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ...

Despite a dip in revenue, Charles River Laboratories International Inc (CRL) boosts earnings per share and strengthens its position in preclinical drug development.

GuruFocus.com 3 days ago

CRL
-1.82%
S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments

The S&P 500 rose 0.4% on Wednesday, May 7, 2025, as investors reviewed the details of today’s Federal Reserve meeting and parsed comments by President Donald Trump on trade with China.

Investopedia 3 days ago

^GSPC

GOOG

DIS
Charles River to initiate a review amid Elliott stake - Is a sale next?

Investing.com -- Charles River Laboratories (NYSE:CRL) announced Wednesday it will appoint four new directors to its board and launch a comprehensive strategic review following a cooperation agreement with activist hedge fund Elliott Investment Management, the company’s largest shareholder. The changes will be overseen by a newly formed Strategic Planning and Capital Allocation Committee aimed at enhancing long-term shareholder value.

Investing.com 3 days ago

CRL
-1.82%
Why Are Charles River Laboratories (CRL) Shares Soaring Today

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 17.3% in the afternoon session after the company reported strong first quarter 2025 results which significantly beat analysts' organic revenue and EPS estimates, and featured a raise to full-year EPS guidance. Zooming out, we think this was a solid print.

StockStory 3 days ago

CRL
-1.82%
Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.

The biotech said its largest investor would conduct a “strategic review” as revenue continued to decline.

Barrons.com 4 days ago

CRL
-1.82%
Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More

U.S. equities were little changed at midday with the market focused on comments from the Federal Reserve coming later today.

Investopedia 4 days ago

SMCI

CRL
-1.82%

DIS
Charles River Labs Stock Soars as Firm Shakes Up Board, Launches Review

Charles River Laboratories stock surged 16% Wednesday morning as the medical testing company made changes to its board and announced a strategic review as it faced pressure from Elliott Investment Management.

Investopedia 4 days ago

CRL
-1.82%
CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up

Charles River delivers better-than-expected earnings and revenues in the first quarter of 2025.

Zacks 4 days ago

CRL
-1.82%

ITGR

BSX
Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics

The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks 4 days ago

CRL
-1.82%
Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%

Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP profit of $2.34 per share was 12.8% above analysts’ consensus estimates.

StockStory 4 days ago

CRL
-1.82%
Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

Charles River (CRL) delivered earnings and revenue surprises of 13.59% and 5.25%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 4 days ago

CRL
-1.82%
Charles River: Q1 Earnings Snapshot

CRL) on Wednesday reported first-quarter profit of $25.5 million. On a per-share basis, the Wilmington, Massachusetts-based company said it had profit of 50 cents. Earnings, adjusted for one-time gains and costs, came to $2.34 per share.

Associated Press Finance 4 days ago

CRL
-1.82%
Charles River Laboratories Announces First-Quarter 2025 Results

WILMINGTON, Mass., May 07, 2025--Charles River Laboratories Announces First-Quarter 2025 Financial Results

Business Wire 4 days ago

CRL
-1.82%
Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

WILMINGTON, Mass., May 07, 2025--Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

Business Wire 4 days ago

CRL
-1.82%
Charles River raises 2025 profit forecast, reaches deal with activist investor

(Reuters) -Charles River Laboratories shares jumped 15% on Wednesday after the company raised its annual profit forecast due to improving demand for contract drug research services. Separately, the Massachusetts-based company also said that it had reached an agreement with activist investor Elliott Management. Charles River's stock climbed to $133.36, though it has fallen approximately 37% year-to-date as the company and other contract drugmakers face sluggish demand among smaller biotech companies, negatively impacting their financial performance.

Reuters 4 days ago

CRL
-1.82%
Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect

Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results tomorrow before the bell. Here’s what to expect.

StockStory 5 days ago

CRL
-1.82%
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 10 days ago

PGNY

CRL
-1.82%
Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025

We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other worst performing stocks this year. After a two-year surge of 53%, marking the best performance for the broad […]

Insider Monkey 10 days ago

CRL
-1.82%

^GSPC

Performance Overview

Return	CRL	S&P 500 (^GSPC)
YTD	-24.82%	-3.77%
1-Year	-39.68%	+8.55%
3-Year	-39.35%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Charles River Laboratories International, Inc. (CRL)

Eli Lilly extends Purdue alliance; EMA investigates Valneva shot

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

Charles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ...

S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments

Charles River to initiate a review amid Elliott stake - Is a sale next?

Why Are Charles River Laboratories (CRL) Shares Soaring Today

Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.

Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More

Charles River Labs Stock Soars as Firm Shakes Up Board, Launches Review

CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up

Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics

Charles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%

Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

Charles River: Q1 Earnings Snapshot

Charles River Laboratories Announces First-Quarter 2025 Results

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

Charles River raises 2025 profit forecast, reaches deal with activist investor

Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect

Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025

Performance Overview